XBIO · CIK 0001534525 · operating
Xenetic Biosciences, Inc. (XBIO) is a pharmaceutical preparations company incorporated in NV, listed on the Nasdaq. With a market capitalization of $6 million, Xenetic Biosciences, Inc. is a micro-cap company. The stock currently trades at $2.52, down 0.40% today, with a 52-week range of $1.90–$13.93.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-2.57 | $-2.57 | +5.2% | |
| 2023 | $-2.71 | $-2.71 | -489.1% | |
| 2022 | $-0.46 | $-0.46 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-18 | 0001683168-25-001686 | SEC ↗ |
| 2023-12-31 | 2024-03-21 | 0001683168-24-001594 | SEC ↗ |
| 2022-12-31 | 2023-03-22 | 0001683168-23-001674 | SEC ↗ |
| 2021-12-31 | 2022-03-22 | 0001683168-22-001839 | SEC ↗ |
| 2020-12-31 | 2021-03-16 | 0001683168-21-000969 | SEC ↗ |
| 2019-12-31 | 2020-03-26 | 0001683168-20-000967 | SEC ↗ |
| 2018-12-31 | 2019-03-29 | 0001683168-19-000840 | SEC ↗ |
| 2017-12-31 | 2018-03-30 | 0001683168-18-000831 | SEC ↗ |
| 2016-12-31 | 2017-03-31 | 0001683168-17-000749 | SEC ↗ |
| 2015-12-31 | 2016-03-30 | 0001019687-16-005662 | SEC ↗ |
| 2014-12-31 | 2015-04-15 | 0001019687-15-001465 | SEC ↗ |
| 2013-12-31 | 2014-04-15 | 0001193125-14-144354 | SEC ↗ |
| 2013-08-31 | 2013-11-27 | 0001255294-13-000958 | SEC ↗ |
| 2012-08-31 | 2012-12-14 | 0001255294-12-000898 | SEC ↗ |